A Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin

Recruiting

Trial locations(27 sites)

United States

Ascendis Investigational Site, Phoenix, Arizona

Ascendis Investigational Site, Orange, California

Ascendis Investigational Site, Sacramento, California

Ascendis Investigational Site, San Francisco, California

Ascendis Pharma Investigational Site, Centennial, Colorado

Ascendis Investigational Site, Washington D.C., District of Columbia

Ascendis Investigational Site, Orlando, Florida

Ascendis Investigational Site, Tampa, Florida

Ascendis Investigational Site, Sandy Springs, Georgia

Ascendis Investigational Site, Boise, Idaho

Ascendis Investigational Site, Indianapolis, Indiana

Ascendis Investigational Site, Iowa City, Iowa

Ascendis Investigational Site, Louisville, Kentucky

Ascendis Investigational Site, Minneapolis, Minnesota

Ascendis Investigational Site, Las Vegas, Nevada

Ascendis Investigational Site, Lebanon, New Hampshire

Ascendis Investigational Site, Manchester, New Hampshire

Ascendis Investigational Site, Morristown, New Jersey

Ascendis Investigational Site, New Hyde Park, New York

Ascendis Investigational Site, Cincinnati, Ohio

Ascendis Investigational Site, Portland, Oregon

Ascendis Investigational Site, Columbia, South Carolina

Ascendis Investigational Site, Dallas, Texas

Ascendis Investigational Site, El Paso, Texas

Ascendis Investigational Site, Norfolk, Virginia

Ascendis Investigational Site, Seattle, Washington